Medications with Generic Name Beginning ‘R’, Page 15

Page 15 of 194 « First Page « … 5 10 … 13 14 15 16 17 … 20 25 30 35 40 … » Last Page »

Raloxifene Hydrochloride

Raloxifene hydrochloride tablets are an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. (1.1) Reduction in risk of invasive…

Amneal Pharmaceuticals LLC27 December 2019

Raloxifene Hydrochloride

Raloxifene HCl tablets USP are an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. (1.1) Reduction in risk of invasive breast…

AvPAK20 January 2020

Evista (Raloxifene Hydrochloride)

EVISTA is an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. (1.1) Reduction in risk of invasive breast cancer in…

Eli Lilly and Company30 January 2020

Raloxifene Hydrochloride

Raloxifene hydrochloride tablets USP is an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. (1.1) Reduction in risk of invasive…

ScieGen Pharmaceuticals Inc29 June 2020

Raloxifene Hydrochloride

Raloxifene hydrochloride tablets USP is an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. (1.1) Reduction in risk of…

Major Pharmaceuticals2 July 2020

Page 15 of 194 « First Page « … 5 10 … 13 14 15 16 17 … 20 25 30 35 40 … » Last Page »

FDA Medwatch

Fusion Health and Vitality Issues Voluntary Nationwide Recall of Core Essential Nutrients and Immune Boost Sublingual Vitamin D3 Due to the Unapproved Use of a Food Additive and Unapproved Marketing Statements
Sun, 22 Nov 2020. Fusion Health and Vitality LLC is voluntarily recalling all 2020 Lots of CORE essential nutrients and Immune Boost Sublingual Vitamin D3. CORE has been found to contain an unapproved food additive, hordenine HCl, rendering it adulterated. Immune…
Fresenius Kabi Issues Voluntary Nationwide Recall of a Single Lot of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine
Wed, 18 Nov 2020. Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to a trace amount of lidocaine present…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.